Combining In Vivo and Organotypic In Vitro Approaches to Assess the Human Relevance of Basimglurant (RG7090), a Potential CAR Activator
Ramona Nudischer(Roche (Switzerland)), Adrian Roth(Roche (Switzerland)), Laurent Gand(Roche (Switzerland)), Lykke Pedersen(Roche (Denmark)), Franziska Boess(Roche (Switzerland)), Cristina Bertinetti‐Lapatki(Roche (Switzerland)), Barbara M. Elcombe, Kasper Renggli(Vectura (Germany)), Larry G. Higgins, Simone Schadt(Roche (Switzerland)), Sabine Sewing, Jean-Christophe Hoflack(Roche (Switzerland)), Audrey Vardy(Ninewells Hospital), Andreas Hierlemann(ETH Zurich), Barbara Lenz(Roche (Switzerland)), Nicholas Flint(Roche (Switzerland))
Cited by 4
Related Papers
Neurosteroid modulation of GABAA receptors
|Progress in Neurobiology|2003|491
Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro
|PLoS ONE|2016|369
SUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells
|The Journal of General Physiology|2003|264